CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

Conditions: HER2-positive Interventions: Drug: CT-0525 Sponsors: Carisma Therapeutics Inc Recruiting

Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials